Tel Aviv University Professor Dan Peer is developing a nanoparticle-based process to target glioblastoma cells, previously considered untreatable.
Nanoparticles were injected into tumors, acting as the drug delivery system. Nucleic acid, with interference RNAs, attached to receptors expressed specifically on glioma cells, and stopped the activity of a key protein that regulates the rapid reproduction of the cancer cells.
The therapy was tested in mouse models affected with gliomas and control groups treated with standard chemotherapy. The results were, according to the researchers, “astonishing.”
Wearable Tech + Digital Health NYC 2015 – June 30 @ New York Academy of Sciences